Diabetic nephropathy (DN), also recognized as diabetic kidney disease, is a kidney malfunction caused by diabetes mellitus. A possible contributing factor to the onset of DN is hyperglycemia. Poorly regulated hyperglycemia can damage blood vessel clusters in the kidneys, leading to kidney damage. Its treatment is difficult and expensive because its causes are extremely complex and poorly understood. Extracts from medicinal plants can be an alternative treatment for DN. The bioactive content in medicinal plants inhibits the progression of DN. This work explores the renoprotective activity and possible mechanisms of various medicinal plant extracts administered to diabetic animal models. Research articles published from 2011 to 2022 were gathered from several databases including PubMed, Scopus, ProQuest, and ScienceDirect to ensure up-to-date findings. Results showed that medicinal plant extracts ameliorated the progression of DN via the reduction in oxidative stress and suppression of inflammation, advanced glycation end-product formation, cell apoptosis, and tissue injury-related protein expression.
29 November 2021 in Journal of Herbmed Pharmacology
Introduction: As single extracts, Coccinia grandis and Blumea balsamifera have been known to have potent antioxidant activities. However, the synergistic antioxidant effect of the combination of these plant extracts was unknown. In this study, the combination of C. grandis and B. balsamifera extracts was investigated for its antioxidant and synergistic properties. Methods: Separately, C. grandis and B. balsamifera leaves were extracted with ethanol. After evaporation, the thick extracts were assayed for their total phenolic content (TPC) and total flavonoid content (TFC). The antioxidant properties of single and combined extracts were measured using the molybdenum(VI) reducing power, ferric reducing antioxidant power (FRAP), 2,2-diphenyl-1-picrylhydrazyl (DPPH), and 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) methods. The possible synergism effect was evaluated using the checkerboard method and the combination index values were also calculated. Results: The TPC and TFC of the B. balsamifera extracts were much greater than that of C. grandis extract. In the molybdenum(VI) reducing power and FRAP assay, the reducing power of the extract combination increased as B. balsamifera extract concentration increased (P < 0.05). In the ABTS+ and DPPH radical scavenging assays, B. balsamifera extract demonstrated a higher antioxidant activity than C. grandis extract (P < 0.05). When combined, increasing the concentration of B. balsamifera caused an increase in the radical scavenging activity (P < 0.05). Synergism was observed in the combination of the extracts with low concentration ratios. Conclusion: In this study, we showed that the combination of C. grandis and B. balsamifera leaf extracts possessed synergistic antioxidant properties.
Avocado peel (Persea americana Mill) and red ginger (Zingiber officinale var. Rubrum) proved to have antidiabetic properties. However, there has been no research on the analysis of antidiabetic activity of the combination of avocado peel and red ginger in functional beverages. This study aims to make functional beverages from the combination of avocado peel and red ginger. Total phenolic content, antioxidant capacity, inhibition of the α-amylase activity, and public preferences towards functional beverages (organoleptic) were then evaluated. Functional beverages were made by brewing the powdered avocado peel and red ginger with 200 ml of hot water (96oC) for 5 minutes. The results showed that the increase of avocado peels amount in the combination coukd increase total phenolic content. The high antioxidant capacity was also found in samples with high content of avoccado peels. The results of inhibition of α-amylase enzyme activity did not show any significant differences. Organoleptic test results showed that there were no significant differences in each sample. The combination of avocado peel and red ginger has the potential to be an antidiabetic functional beverage.
Combining plant extracts at lower doses may enhance antioxidant effects through synergy. This study investigated the antioxidant capacity of combined Mangifera indica and Euphorbia hirta leaf extracts using metal ion-reducing power assays. The extracts were prepared via maceration with 70% ethanol. Phytochemical profiling was conducted through preliminary screening tests. Antioxidant capacity was assessed spectrophotometrically using the phosphomolybdenum and ferric reducing antioxidant power (FRAP) assays. The phosphomolybdenum assay involved incubation of the extracts with reagent at 95°C for 90 minutes, while the FRAP assay was conducted at 37°C for 15 minutes. Extract combinations were prepared in the ratios of 1:3, 1:1, and 3:1. Phytochemical screening revealed the presence of alkaloids, phenolics, flavonoids, steroids, and terpenoids in both extracts. In the phosphomolybdenum assay, the Mo(VI) reducing power of M. indica extract (29.154±0.664 mg AAE/g extract) was higher than that of E. hirta (27.948±0.667 mg AAE/g extract). Similarly, in the FRAP assay, the ferric reducing power of M. indica extract (55.304±1.284 mg AAE/g extract) exceeded that of E. hirta (48.009±1.873 mg AAE/g extract). The highest reducing powers were observed in Comb. 3, yielding 30.745±0.715 mg AAE/g extract (phosphomolybdenum) and 57.190±1.431 mg AAE/g extract (FRAP). Among the three combinations tested, only the 3:1 ratio demonstrated a synergistic antioxidant effect in both assays.
7 February 2020 in Asian Journal of Pharmaceutical and Clinical Research
Objective: The combination of two or more plants in a product can improve the nature of the activity of the compounds contained and reduce toxicity. This study was aimed to make water extracts from the combination of Coccinia grandis (L.) CG Voigt and Averrhoa bilimbi L. (AB) with antidiabetic properties. Methods: The water extracts were made by decocting the combination of powdered CG Voigt leaves and AB fruits at various mass ratios (1:0, 1:3, 1:1, 3:1, and 0:1) and various amounts of powdered samples (1–5 g). The process was done in 100 ml of boiling water for 5 min. Results: The results showed that the highest total flavonoid content and total phenolic content of 135.1±0.18 mg quercetin equivalent micrograms d.m. and 48.5±3.09 mg gallic acid equivalent/g d.m., respectively, were found in the sample with a combination ratio of 1:3 (1 g). The antioxidant activity test using the 2,2-diphenyl-1-picrylhydrazyl method showed that the sample with a combination ratio of 3:1 had the lowest value of IC50 (4.447±0.446 mg/ml), which indicated the strongest radical scavenging activity, while the highest inhibition of α-amylase activity in the sample with a combination ratio of 1:1 amounted to 1.086±0.264 mg/ml. Conclusion: In general, all combinations of CG Voigt leaves and AB fruits had the potential as antidiabetic health beverages.
7 November 2018 in Asian Journal of Pharmaceutical and Clinical Research
Objective: As an antidiabetic drug, metformin hydrochloride (HCl) has been well known to possess low oral bioavailability and short half-life. In this study, we prepared the drug delivery system (DDS) of metformin HCl and clinoptilolite as its carrier. The in vitro drug release profile was further investigated.Methods: DDS was made by encapsulating metformin HCl on clinoptilolite using the wet impregnation method at various pH and initial concentration of metformin HCl. Fourier transform infrared spectrometer (FTIR), X-ray diffractometer (XRD), and N2 Sorption Analyzer were used to characterize the as-synthesized DDS. Drug release study was conducted by stirring the DDS in simulated gastric fluid and simulated intestinal fluid over 12 h.Results: The encapsulation process was achieved optimally at pH 7.0 and initial concentration of metformin HCl of 300 mg/l (CLI2-300 denoted DDS). The results of FTIR and N2 sorption analyzer confirmed the existence of metformin HCl on clinoptilolites. Meanwhile, the XRD result showed that the crystallinity of clinoptilolites remained unchanged after the encapsulation process. The cumulative drug release in the simulated gastric fluid was found to be higher than that in the simulated intestinal fluid, which indicated the potent influence of pH on the release properties of the drugs. The drug release kinetics of metformin HCl from clinoptilolite was best fitted into the Korsmeyer-Peppas model with non-Fickian transport mechanism.Conclusion: We found that clinoptilolite was suitable for DDS application, particularly as a carrier of metformin HCl.